BHVN logo

BHVN Return On Equity

Annual ROE

-95.37%
+10.48%+9.90%

December 31, 2023


Summary


Performance

BHVN ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNprofitabilitymetrics:

Quarterly ROE

-225.12%
-12.29%-5.77%

September 30, 2024


Summary


Performance

BHVN Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

BHVN ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.9%-117.5%
3 y3 years+86.5%-18.6%
5 y5 years+40.3%-18.6%

BHVN ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+84.5%-117.5%+61.6%
5 y5-year-101.3%+86.5%-110.7%+81.7%
alltimeall time-101.3%+89.2%-110.7%+81.7%

Biohaven Pharmaceutical Holding ROE History

DateAnnualQuarterly
Sep 2024
-
-225.12%(+5.8%)
Jun 2024
-
-212.83%(+44.7%)
Mar 2024
-
-147.06%(+42.1%)
Dec 2023
-95.37%(-9.9%)
-103.50%(-6.0%)
Sep 2023
-
-110.06%(-4.3%)
Jun 2023
-
-114.99%(-27.4%)
Mar 2023
-
-158.35%(-16.6%)
Dec 2022
-105.85%(-82.8%)
-189.84%(-40.3%)
Sep 2022
-
-318.07%(+16.1%)
Jun 2022
-
-273.86%(-53.3%)
Mar 2022
-
-585.98%(+91.3%)
Dec 2021
-616.29%(-12.8%)
-
Dec 2021
-
-306.28%(-539.4%)
Sep 2021
-
69.70%(-49.1%)
Jun 2021
-
137.01%(-50.9%)
Mar 2021
-
279.15%(-53.0%)
Dec 2020
-707.16%
-
Dec 2020
-
594.12%(-71.6%)
Sep 2020
-
2095.32%(-270.3%)
DateAnnualQuarterly
Jun 2020
-
-1230.64%(+102.2%)
Mar 2020
-
-608.62%(+13.7%)
Dec 2019
7122.91%(-4561.9%)
-
Dec 2019
-
-535.09%(+70.5%)
Sep 2019
-
-313.77%(+0.8%)
Jun 2019
-
-311.35%(+54.6%)
Mar 2019
-
-201.37%(-7.4%)
Dec 2018
-159.64%(+65.6%)
-
Dec 2018
-
-217.35%(+8.1%)
Sep 2018
-
-200.98%(+32.8%)
Jun 2018
-
-151.30%(+14.9%)
Mar 2018
-
-131.72%(+10.7%)
Dec 2017
-96.38%(-168.2%)
-
Dec 2017
-
-119.02%(-40.8%)
Sep 2017
-
-200.88%(-43.2%)
Jun 2017
-
-353.48%(-319.2%)
Mar 2017
-
161.26%(+14.0%)
Dec 2016
141.40%(-116.1%)
-
Dec 2016
-
141.40%
Dec 2015
-879.55%
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual return on equity?
  • What is the all time high annual ROE for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual ROE year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly return on equity?
  • What is the all time high quarterly ROE for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly ROE year-on-year change?

What is Biohaven Pharmaceutical Holding annual return on equity?

The current annual ROE of BHVN is -95.37%

What is the all time high annual ROE for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual return on equity is 7122.91%

What is Biohaven Pharmaceutical Holding annual ROE year-on-year change?

Over the past year, BHVN annual return on equity has changed by +10.48% (+9.90%)

What is Biohaven Pharmaceutical Holding quarterly return on equity?

The current quarterly ROE of BHVN is -225.12%

What is the all time high quarterly ROE for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly return on equity is 2095.32%

What is Biohaven Pharmaceutical Holding quarterly ROE year-on-year change?

Over the past year, BHVN quarterly return on equity has changed by -121.62% (-117.51%)